18 results
424B3
EVOK
Evoke Pharma Inc
14 Mar 24
Prospectus supplement
6:44pm
authorities. The drug-related side effects could also affect patient recruitment for our clinical trials, or the ability of enrolled patients
424B5
1cedtp
22 Jul 16
Prospectus supplement for primary offering
12:00am
424B5
72i i1n60m
20 Jul 16
Prospectus supplement for primary offering
12:00am
8-K
EX-99.2
aexpjqney8k9 t2
20 Jul 16
Evoke Pharma Announces $4.5 Million At-The-Market Offering
12:00am
8-K
EX-99.1
hltsgjxyfvx23 zppqc
4 Mar 15
Results of Operations and Financial Condition
12:00am
- Prev
- 1
- Next